Companies Mentioned

Mylan Pharmaceutical, Inc.

Category
Title
Summary
Date
Commentaries
Patent Law

In KSR v. Teleflex, 550 U.S. ____, 127 S. Ct. 1727 (2007), the U.S. Supreme Court broadened the applicable test in determining whether an invention is “obvious.” As predicted by patent law pundits, the KSR decision was followed by a number of cases in which infringers defended their actions –…
Posted:
05/16/2008
Summaries
Patent Law >
New Judicial Opinions

Patent (‘006 patent) at issue relates to Topiramate, a drug that is distributed by plaintiff Ortho-McNeil Pharmaceutical, Inc. (“plaintiff”) as Topomax.  It is a significant epilepsy drug that was formulated during a search for new anti-diabetic drugs. On the other hand, defendant Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. (“defendant”)…
Date of ruling:
03/31/2008
The most advanced document                
         management system in the world.

Only $59 / person / month
FeaturesLawLoop Demo
FeaturesWelcome to the Future
Play LawLoop Demo